(Q44423210)

2 December 2017

title

Effect of metformin and sulfonylurea on C-reactive protein level in well-controlled type 2 diabetics with metabolic syndrome (English)

1 reference

2 December 2017

Effect of Metformin and Sulfonylurea on C-Reactive Protein Level in Well-Controlled Type 2 Diabetics with Metabolic Syndrome (English)

1 reference

Crossref

DOI

https://api.crossref.org/works/10.1385/ENDO:20:3:215

28 December 2023

1 reference

1 reference

https://api.crossref.org/works/10.1385/ENDO:20:3:215

28 December 2023

author name string

Daad Hassan Akbar

series ordinal

1

1 reference

2 December 2017

language of work or name

1 reference

1 April 2003

1 reference

full work available at URL

2 December 2017

http://www.springerlink.com/index/pdf/10.1385/ENDO:20:3:215

1 reference

Crossref

DOI

https://api.crossref.org/works/10.1385/ENDO:20:3:215

28 December 2023

1 reference

2 December 2017

volume

20

1 reference

2 December 2017

issue

3

1 reference

2 December 2017

page(s)

215-218

1 reference

Production of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group

2 December 2017

cites work

1 reference

12 December 2020

Cardiovascular events and correlates in the Veterans Affairs Diabetes Feasibility Trial. Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type II Diabetes

1 reference

12 December 2020

Cardiovascular morbidity and mortality associated with the metabolic syndrome

1 reference

12 December 2020

Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation

1 reference

12 December 2020

[The female sex is an independent prognostic factor for mortality in the acute phase of myocardial infarction]

1 reference

12 December 2020

Association between C-reactive protein and features of the metabolic syndrome: a population-based study

1 reference

12 December 2020

Prospective analysis of the insulin-resistance syndrome (syndrome X).

1 reference

12 December 2020

Increased levels of acute-phase serum proteins in diabetes.

1 reference

12 December 2020

Insulin resistance syndrome predicts the risk of coronary heart disease and stroke in healthy middle-aged men: the 22-year follow-up results of the Helsinki Policemen Study

1 reference

12 December 2020

Plasma fibrinogen: a new factor of the metabolic syndrome. A population-based study.

1 reference

12 December 2020

C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study

1 reference

12 December 2020

Diabetes, fibrinogen, and risk of cardiovascular disease: the Framingham experience

1 reference

12 December 2020

The influence of improved glycaemic control with insulin and sulphonylureas on acute phase and endothelial markers in Type II diabetic subjects

1 reference

12 December 2020

Sulfonylureas in NIDDM.

1 reference

12 December 2020

Effect of diabetes mellitus on short- and long-term mortality rates of patients with acute myocardial infarction: a statewide study. Myocardial Infarction Data Acquisition System Study Group

1 reference

12 December 2020

Effect of troglitazone on fibrinolysis and activated coagulation in patients with non-insulin-dependent diabetes mellitus

1 reference

12 December 2020

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

1 reference

12 December 2020

Differential effects of metformin and troglitazone on cardiovascular risk factors in patients with type 2 diabetes

1 reference

12 December 2020

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

12 December 2020

Associations of C-reactive protein with measures of obesity, insulin resistance, and subclinical atherosclerosis in healthy, middle-aged women

1 reference

12 December 2020

Lifetime smoking exposure affects the association of C-reactive protein with cardiovascular disease risk factors and subclinical disease in healthy elderly subjects

1 reference

12 December 2020

1 reference

12 December 2020

The treatment of elderly diabetic patients with acute myocardial infarction: insight from Michigan's Cooperative Cardiovascular Project

1 reference

12 December 2020

The deadly quartet. Upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension

1 reference

12 December 2020

Troglitazone decreases the proportion of small, dense LDL and increases the resistance of LDL to oxidation in obese subjects.

1 reference

12 December 2020

Relationship of proinsulin and insulin to cardiovascular risk factors in nondiabetic subjects.

1 reference

12 December 2020

Insulin resistance and hyperinsulinemia in individuals with small, dense low density lipoprotein particles

1 reference

12 December 2020

Hyperinsulinemia as an independent risk factor for ischemic heart disease.

1 reference

12 December 2020

Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease

1 reference

12 December 2020

5-year incidence of atherosclerotic vascular disease in relation to general risk factors, insulin level, and abnormalities in lipoprotein composition in non-insulin-dependent diabetic and nondiabetic subjects.

1 reference

12 December 2020

Sex differences in early mortality after acute myocardial infarction (the Minnesota Heart Survey)

1 reference

12 December 2020

Potent inhibitory effect of troglitazone on carotid arterial wall thickness in type 2 diabetes

1 reference

12 December 2020

C-reactive protein: binding to lipids and lipoproteins

1 reference

12 December 2020

Insulin sensitivity in subjects with type 2 diabetes. Relationship to cardiovascular risk factors: the Insulin Resistance Atherosclerosis Study

1 reference

12 December 2020

C-reactive protein: relation to total mortality, cardiovascular mortality and cardiovascular risk factors in men

1 reference

12 December 2020

Risk factors for coronary heart disease and acute-phase proteins. A population-based study

1 reference

12 December 2020

Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Multiple Risk Factor Intervention Trial

1 reference

12 December 2020

NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X.

1 reference

12 December 2020

Cardiovascular disease in diabetes mellitus type 2: a potential role for novel cardiovascular risk factors

1 reference

12 December 2020

Platelet plasminogen activator inhibitor 1 in patients with type II diabetes.

1 reference

12 December 2020

C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor

1 reference

12 December 2020

Relation of components of insulin resistance syndrome to coronary disease risk

1 reference

12 December 2020

Banting lecture 1988. Role of insulin resistance in human disease

1 reference

12 December 2020

C-reactive protein as a cardiovascular risk factor: more than an epiphenomenon?

1 reference

12 December 2020

Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Results from the Cardiovascular Health Study and the Rural Health Promotion Project.

1 reference

12 December 2020

Coronary heart disease mortality in relation with diabetes, blood glucose and plasma insulin levels. The Paris Prospective Study, ten years later.

1 reference

12 December 2020

Identifiers

DOI

1 reference

Dimensions Publication ID

2 December 2017

1031202597

0 references

1 reference